ARCHIVES

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

March 31, 2006

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

November 27, 1987

Patient Advocacy: Breast Cancer Coalition To Hold International Meeting In Brussels

January 17, 1997

RFA On Breast Tumor Factors Patients Survival

June 20, 1980

In Brief: Livingston Completes Term On NCI Board, Appelbaum To Succeed Him as Chairman

November 12, 1999